My friend and fellow CLLer, Andrew Schorr, asked to interview me to give patient's perspective for his helpful website, Patient Power when we both at the iwCLL meeting in Koln, Germany. I was happy to help.
When I attend these meetings I attend first and foremost as a patient, trying to learn what's new for myself and others with CLL, perhaps most importantly as an advocate, pushing patients' needs and priorities to anyone who will listen and who may have the influence to make a difference, as a doctor, gathering information to help my personal patients and to better understand the CLL disease state and its therapy as it relates to other similar medical conditions, as a reporter and blogger, bringing the latest news and interviews, and finally as an "on air" talking head in the video interviews.
No wonder I get tired.
Here's my interview with Andrew on my take from iwCLL. Enjoy.
Community Magazine
Author's Latest Articles
-
A Matching-Adjusted Indirect Comparison of Acalabrutinib Vs. Zanubrutinib in Relapsed Or Refractory CLL
-
My Personal Decision to Restart My CLL (chronic Lymphocytic Leukemia) Treatment
-
ASH 2022: Adverse Events from BTK Inhibitors in Clinical Trials
-
Dr. Stephan Stilgenbauer on the Evolution of CLL to Richter’s Syndrome from ASH 2022